Dow 
0.22% Nasdaq 0.98%
0.22% Nasdaq 0.98%Dec 4: 1.35 
0.04 (2.88%)
0.04 (2.88%) Nile Therapeutics, Inc (NLTX)
Compare NLTX to:
- Dow Jones (^DJI)
- NASDAQ (^IXIC)
- S&P 500 (^GSPC)
Nile Therapeutics, Inc.
(NasdaqCM: NLTX)After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 1.35 |
|---|---|
| Trade Time: | Dec 4 |
| Change: | 0.04 (2.88%) |
| Prev Close: | 1.39 |
| Open: | 1.36 |
| Bid: | N/A |
| Ask: | 3.60 x 3000 |
| 1y Target Est: | 5.00 |
| Day's Range: | 1.35 - 1.36 |
|---|---|
| 52wk Range: | 0.25 - 2.30 |
| Volume: | 9,452 |
| Avg Vol (3m): | 24,439.1 |
| Market Cap: | 36.53M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.38 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.
Headlines
| Wed, Nov 18 | NILE THERAPEUTICS, INC. FinancialsEDGAR Online Financials |
| Sun, Nov 15 | New Star Analyst Rankings for Nile Therapeutics, Inc.StarMine |
| Thu, Nov 12 | Nile Therapeutics Reports 2009 Third Quarter Financial ResultsBusiness Wire |
| Thu, Nov 12 | NILE THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Tue, Sep 29 | NILE THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibEDGAR Online |
| Tue, Sep 29 | Nile Therapeutics Appoints Arie S. Belldegrun, M.D., to Board of DirectorsPR Newswire |
| Fri, Sep 25 | Nile Therapeutics names Dr. Frank Litvack to boardAP |
| Mon, Sep 14 | Nile Therapeutics Announces Poster Presentation at 2009 Heart Failure Society of America Annual MeetingPR Newswire |
| Tue, Aug 18 | NILE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EEDGAR Online |
| Thu, Aug 13 | NILE THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.